Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial.
Nicola S Vos, Nick D Fagel, Giovanni Amoroso...
https://pubmed.ncbi.nlm.nih.gov/31126887/Actively Recruiting
Led by Xijing Hospital · Updated on 2026-09-08
668
Participants Needed
1
Research Sites
30 weeks
Total Duration
Researchers are conducting a single-center, retrospective observational study to compare immediate blood flow complications after emergency heart procedures in patients with acute ST-elevation myocardial infarction STEMI who have a high amount of blood clots in their arteries. The study evaluates two types of devices used during percutaneous coronary intervention PCI drug-coated balloons DCB and drug-eluting stents DES. Medical records of patients treated between 2019 and 2025 will be reviewed, with statistical methods used to balance patient characteristics between groups. Both immediate procedural outcomes and clinical events occurring within one year after treatment will be analyzed. The study groups include STEMI patients with high thrombus burden who received either DCB or DES as their final treatment strategy for the blocked coronary artery. The DCB involves a balloon coated with an anti-proliferative drug delivered during inflation without leaving a permanent metal scaffold, while DES involves implanting a metal scaffold that releases medication to keep the artery open. Some patients may have received bailout DES after DCB predilation. The study compares these two approaches to see differences in immediate slow or no blood flow after PCI and longer-term clinical outcomes. Participants are identified retrospectively through medical records, focusing on those who underwent emergency PCI within 12 hours of symptom onset or later if symptoms persist, with specific angiographic and vessel size criteria. Researchers will review coronary angiographic images before and after the procedure and collect clinical follow-up data for one year. The main outcome measured is the incidence of immediate slow or no blood flow after PCI, with secondary outcomes including various composite clinical endpoints and bleeding events over one year. The study is sponsored by Xijing Hospital and will be completed by January 2028.
CONDITIONS
A Single-Center, Retrospective, Propensity-Score-Matched Cohort Study Comparing Drug-Coated Balloon Versus Drug-Eluting Stent for Reducing Immediate Post-Procedural Slow-Flow/No-Reflow in Acute ST-Elevation Myocardial Infarction Patients With High Thrombus Burden
Y
Yuan He, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Xijing Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (retrospective record review)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Nicola S Vos, Nick D Fagel, Giovanni Amoroso...
https://pubmed.ncbi.nlm.nih.gov/31126887/Edina Cenko, Lina Badimon, Giuseppe Vadalà...
https://pubmed.ncbi.nlm.nih.gov/42185090/Xijing Hospital
Lead Sponsor